|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.3 NOK | -2.51% |
|
-3.72% | 0.00% |
| Apr. 24 | Vistin Pharma ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 24 | Transcript : Vistin Pharma ASA, Q1 2024 Earnings Call, Apr 24, 2024 |
Vistin Pharma ASA reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was NOK 100.94 million compared to NOK 33.22 million a year ago. Net loss was NOK 2.98 million compared to NOK 15.15 million a year ago.
Basic loss per share from continuing operations was NOK 0.07 compared to NOK 0.34 a year ago. Diluted loss per share from continuing operations was NOK 0.07 compared to NOK 0.34 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 95.97M | |
| +20.81% | 43.34B | |
| +20.44% | 21.96B | |
| +13.30% | 14.09B | |
| +12.97% | 13.64B | |
| +39.74% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
VISTIN PHARMA ASA 
